Agios Pharmaceuticals, Inc. (LON:0HB0)

Agios Pharmaceuticals Statistics

Total Valuation

LON:0HB0 has a market cap or net worth of GBP 1.56 billion. The enterprise value is 617.59 million.

Market Cap	1.56B
Enterprise Value	617.59M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	58.10M
Shares Outstanding	n/a
Shares Change (YoY)	+3.93%
Shares Change (QoQ)	+0.82%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	51.36M

Valuation Ratios

The trailing PE ratio is 3.29.

PE Ratio	3.29
Forward PE	n/a
PS Ratio	52.40
PB Ratio	1.56
P/TBV Ratio	1.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.30
EV / Sales	20.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.07

Financial Position

The company has a current ratio of 14.48, with a Debt / Equity ratio of 0.04.

Current Ratio	14.48
Quick Ratio	13.41
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 64.05% and return on invested capital (ROIC) is -26.92%.

Return on Equity (ROE)	64.05%
Return on Assets (ROA)	-25.71%
Return on Invested Capital (ROIC)	-26.92%
Return on Capital Employed (ROCE)	-32.95%
Revenue Per Employee	61,262
Profits Per Employee	974,324
Employee Count	488
Asset Turnover	0.04
Inventory Turnover	11.86

Taxes

In the past 12 months, LON:0HB0 has paid 32.29 million in taxes.

Income Tax	32.29M
Effective Tax Rate	6.37%

Stock Price Statistics

The stock price has decreased by -22.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.33%
50-Day Moving Average	37.40
200-Day Moving Average	36.42
Relative Strength Index (RSI)	49.27
Average Volume (20 Days)	458

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.90

Income Statement

In the last 12 months, LON:0HB0 had revenue of GBP 29.83 million and earned 474.50 million in profits. Earnings per share was 8.12.

Revenue	29.83M
Gross Profit	-207.22M
Operating Income	-336.87M
Pretax Income	506.79M
Net Income	474.50M
EBITDA	-333.04M
EBIT	-336.87M
Earnings Per Share (EPS)	8.12

Balance Sheet

The company has 685.33 million in cash and 35.59 million in debt, giving a net cash position of 942.04 million.

Cash & Cash Equivalents	685.33M
Total Debt	35.59M
Net Cash	942.04M
Net Cash Per Share	n/a
Equity (Book Value)	999.64M
Book Value Per Share	17.22
Working Capital	692.71M

Cash Flow

In the last 12 months, operating cash flow was -296.34 million and capital expenditures -2.21 million, giving a free cash flow of -298.55 million.

Operating Cash Flow	-296.34M
Capital Expenditures	-2.21M
Free Cash Flow	-298.55M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,129.13%
Pretax Margin	1,698.66%
Profit Margin	1,590.42%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0HB0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.93%
Shareholder Yield	n/a
Earnings Yield	30.35%
FCF Yield	-19.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HB0 has an Altman Z-Score of 12.63 and a Piotroski F-Score of 4.

Altman Z-Score	12.63
Piotroski F-Score	4